Cuba launches clinic for chikungunya aftereffects

The Institute of Neurology and Neurosurgery in Cuba has begun a specialized clinic to care for patients with post-chikungunya ailments, particularly those linked to neuropathic pain, joint pain, and paresthesia. This step provides focused treatment for individuals impacted by the mosquito-borne virus.

In Havana on December 23, the Institute of Neurology and Neurosurgery in Cuba has launched a specialized clinic dedicated to treating patients with post-chikungunya ailments. The facility focuses on conditions such as neuropathic pain, joint pain, and paresthesia, which are common lingering effects of the mosquito-borne chikungunya virus that causes fever and severe aches.

Chikungunya can lead to long-term complications that impair daily life for those infected. The new clinic aims to address these persistent issues through comprehensive care. As reported by Prensa Latina, this opening meets the demand for specialized health services in Cuba.

While specific patient numbers are not yet available, the clinic is part of Cuba's public health efforts to manage infectious diseases and their neurological aftermaths. This initiative highlights Cuba's dedication to accessible medical treatment for virus-related conditions.

Verwandte Artikel

Comparative illustration of long COVID patients: US woman with severe brain fog and anxiety versus milder symptoms in India, Nigeria, and Colombia, per international study.
Bild generiert von KI

International study finds U.S. long COVID patients report more brain fog and psychological symptoms than peers in India and Nigeria

Von KI berichtet Bild generiert von KI Fakten geprüft

A Northwestern Medicine-led study of more than 3,100 adults with long COVID found that non-hospitalized participants in the United States reported substantially higher rates of brain fog, depression/anxiety and insomnia than participants in Colombia, Nigeria and India—differences the researchers say likely reflect cultural factors and access to care as much as biology.

Der kubanische Präsident Miguel Díaz-Canel legte vorläufige positive Ergebnisse aus klinischen Studien des Biotechnologiemedikaments Jusvinza bei Patienten mit chronischer post-Chikungunya-Arthritis vor. Die im Dezember 2025 gestarteten Studien zeigen deutliche Verbesserungen in Provinzen wie Havanna und Matanzas. Experten heben das Sicherheitsprofil des Medikaments und sein Potenzial zur Verlangsamung der Entzündung hervor.

Von KI berichtet

Kuba weist eine günstige epidemiologische Situation in der Bekämpfung von Arboviren auf, nach einem Rückgang der gemeldeten Fieberfälle um 21 Prozent in der vergangenen Woche. Diese Verbesserung unterstreicht die effektiven Bemühungen zur Kontrolle von Vektorkrankheiten wie Dengue und Zika. Gesundheitsbehörden betonen die Notwendigkeit anhaltender Wachsamkeit.

Das kenianische Gesundheitsministerium hat Bürger vor nicht notwendigen Reisen in Teile Indiens gewarnt, nachdem zwei Fälle von Nipah-Virus in Westbengalen bestätigt wurden. Das Risiko einer Ausbreitung der Krankheit nach Kenia bleibt gering, aber die Behörden fordern strenge persönliche Hygiene für Reisende. Die Weltgesundheitsorganisation hat den Ausbruch dieser seltenen, aber schweren Erkrankung bestätigt.

Von KI berichtet

In Brazil's shrinking Atlantic Forest, deforestation is causing mosquitoes to increasingly feed on humans, heightening the risk of diseases like dengue and Zika. A new study reveals that out of identified blood meals, most came from people rather than wildlife. This adaptation underscores how habitat loss alters disease transmission patterns.

Researchers from Weill Cornell Medicine and Wake Forest University School of Medicine have identified a stress-response pathway in immune cells that is activated by chemotherapy and leads to painful nerve damage. In mice, blocking this pathway with a drug already in early-stage cancer trials reduced signs of nerve injury, and a small patient study suggests a blood test might one day predict who is most at risk.

Von KI berichtet

The Don Benito Health Area has confirmed the death of a 15-year-old teenager from meningoencephalitis caused by reactivation of type 6 virus. The death occurred on March 13 at Vegas Altas hospital. Health authorities state that this variant does not require epidemiological surveillance or specific protocols.

 

 

 

Diese Website verwendet Cookies

Wir verwenden Cookies für Analysen, um unsere Website zu verbessern. Lesen Sie unsere Datenschutzrichtlinie für weitere Informationen.
Ablehnen